COLLIN MALONEY: Open Payments
NPI 1831505148 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 101 payments from 9 companies in 2025. Trend: 2023 $724 · 2024 $1,187 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $445 |
| PFIZER INC. | 31 | $341 |
| CATALYST PHARMACEUTICALS, INC. | 6 | $126 |
| UCB, Inc. | 3 | $81 |
| Lilly USA, LLC | 3 | $57 |
| Alexion Pharmaceuticals, Inc. | 3 | $54 |
| Neurelis, Inc. | 2 | $51 |
| SK Life Science, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, FYCOMPA, KISUNLA, ULTOMIRIS, VALTOCO, BOTOX.
Industry payments across NY — which companies pay providers there.
